PD-1/PD-L1 inhibitor treatment and its impact on clinical imaging in non-small cell lung cancer: a systematic review and meta-analysis of immune-related adverse events

BACKGROUND: In the contemporary era of cancer treatment, lung cancer (LC) holds the unenviable position of being the primary contributor to cancer-induced mortality worldwide. Although immunotherapy has expanded the therapeutic landscape for metastatic non-small cell lung cancer (NSCLC), the advent...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammed, Nader, Xiao, En-Hua, Mohsen, Shallal, Xiong, Zeng, Zhou, RongRong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571717/
https://www.ncbi.nlm.nih.gov/pubmed/37841435
http://dx.doi.org/10.3389/fonc.2023.1191681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571717/
https://www.ncbi.nlm.nih.gov/pubmed/37841435
http://dx.doi.org/10.3389/fonc.2023.1191681

Ejemplares similares